MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

Search

West Pharmaceutical Services Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

274.76 1.18

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

270.33

Max

278.16

Pagrindiniai rodikliai

By Trading Economics

Pajamos

8.2M

140M

Pardavimai

38M

804M

P/E

Sektoriaus vid.

40.491

90.831

Dividendų pajamingumas

0.3

Pelno marža

17.406

Darbuotojai

10,600

EBITDA

19M

217M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+28.28% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.30%

2.20%

Kitas uždarbis

2026-02-12

Kitas dividendų mokėjimo data

2026-02-04

Kita Ex Dividend data

2026-01-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-133M

20B

Ankstesnė atidarymo kaina

273.58

Ankstesnė uždarymo kaina

274.76

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-12 11:40; UTC

Įsigijimai, susijungimai, perėmimai

AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma

2026-01-12 11:02; UTC

Įsigijimai, susijungimai, perėmimai

AbbVie to Invest More Than $175 Million to Acquire, Modernize, Integrate Plant >ABBV WST

2026-01-12 11:01; UTC

Įsigijimai, susijungimai, perėmimai

AbbVie Plans to Hire About 200 Employees at Acquired Site >ABBV WST

2026-01-12 11:01; UTC

Įsigijimai, susijungimai, perėmimai

AbbVie To Buy Device Manufacturing Plant in Tempe, Ariz., Associated Intellectual Property From West >ABBV

2026-01-12 11:00; UTC

Įsigijimai, susijungimai, perėmimai

AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in U.S. >ABBV WST

Akcijų palyginimas

Kainos pokytis

West Pharmaceutical Services Inc Prognozė

Kainos tikslas

By TipRanks

28.28% į viršų

12 mėnesių prognozė

Vidutinis 348.7 USD  28.28%

Aukščiausias 375 USD

Žemiausias 285 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines West Pharmaceutical Services Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

10

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

213.26 / 219.27Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat